Drug
Tab006
Tab006: highest development phase Phase 1, developed by Junshi Biosciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Junshi Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| TAB006 NCT05253105 | Phase 1 | Previously Treated, Advanced |
Latest
No recent events.
Follow Tab006 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.